TMO
Thermo Fisher Scientific Inc
675.00$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 15.3% | 14.1% | 15.3% | 16.6% | 18.9% | 20.4% | 31.8% | 21.1% | 26.0% | 24.9% | 22.7% | 26.0% | |
| 3.1% | 1.1% | 1.7% | 2.4% | 3.7% | 4.1% | 15.0% | 4.7% | 8.8% | 8.2% | 4.1% | 8.9% | |
| 3.1% | 1.1% | 1.7% | 2.4% | 3.7% | 4.1% | 15.0% | 4.7% | 8.8% | 8.2% | 5.7% | 9.2% | |
| 5.8% | 6.2% | 6.6% | 6.8% | 8.2% | 8.5% | 9.4% | 9.4% | 9.7% | 9.8% | 9.9% | 9.6% | |
| 4.3% | 4.9% | 4.8% | 5.2% | 5.3% | 5.8% | 5.8% | 5.3% | 5.8% | 5.2% | 5.1% | 4.9% | |
| 5.7% | 6.0% | 5.6% | 7.1% | 7.4% | 8.1% | 8.6% | 8.8% | 9.6% | 11.1% | 11.1% | 9.6% | |
| 44.0% | 46.1% | 46.5% | 44.6% | 45.1% | 44.0% | 37.7% | 44.1% | 42.4% | 44.6% | 47.1% | 44.7% | |
| 32.9% | 31.2% | 30.4% | 29.4% | 26.6% | 24.0% | 18.4% | 21.2% | 18.0% | 16.9% | 16.0% | 14.4% | |
| 52.0% | 47.7% | 53.1% | 55.2% | 50.9% | 49.2% | 50.0% | 56.9% | 54.6% | 52.6% | 49.0% | 51.5% | |
| 12.5% | 10.2% | 10.6% | 12.4% | 10.9% | 10.6% | 14.9% | 14.1% | 17.5% | 14.2% | 13.7% | 13.8% | |
| 5.2% | 2.6% | 4.6% | 3.8% | 2.3% | 1.4% | 4.1% | 2.9% | 6.0% | 3.9% | 2.5% | 3.2% | |
| 1.9% | 2.0% | 2.0% | 2.5% | 2.9% | 3.3% | 3.1% | 3.0% | 3.5% | 2.9% | 3.2% | 3.3% | |
| 28.8% | 28.0% | 33.5% | 33.3% | 31.5% | 29.2% | 27.7% | 34.0% | 29.8% | 31.7% | 29.9% | 32.5% | |
| 48.0% | 52.3% | 46.9% | 44.8% | 49.1% | 50.8% | 50.0% | 42.9% | 45.3% | 47.3% | 50.9% | 48.4% | |
| 24.3% | 29.7% | 30.3% | 28.1% | 33.2% | 37.8% | 40.7% | 37.2% | 43.1% | 48.0% | 54.6% | 53.6% | |
| 0.9% | 1.0% | 0.9% | 0.7% | 0.7% | 0.7% | 0.6% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.